INTRODUCTION
============

Shock is a severe condition characterized by inadequate perfusion and subsequent injury of vital organs such as the kidney. Acute kidney injury (AKI) increases morbidity and mortality ([@R1]). Underlying mechanisms include hypoperfusion and direct membrane and cellular injury due to oxidative stress, inflammation, toxicity of drugs, and damage proteins ([@R2]).

Routine monitoring of the circulation includes pressure as well as flow measurements in the macrocirculation to guide the administration of fluids and vasoactive medication. However, it does not include the renal circulation. Nowadays, ultrasound has become an important tool to assess the circulation in critically ill patients. The renal circulation can be assessed using Doppler ultrasound, a non-invasive tool which has recently become available at the bedside ([@R3]). Renal resistive index (RRI) is a sonographic index assessing the resistance to flow in intrarenal arcuate or interlobar arteries. High RRI can be caused by vasoconstriction, decreased vascular compliance, or capillary rarefaction, and is associated with renal arterial disease ([@R4]). RRI seems a promising tool to predict the development and reversibility of AKI in critically ill patients ([@R5]--[@R7]). Up to now, there are no studies in intensive care patients showing that RRI is increased in shock. Furthermore, it is not well known to what extent RRI reflects *pressure* or *flow* indices and whether it reflects changes in the *macro*-, *micro*circulation, or fluid status ([@R8]). Before deciding whether RRI should be part of vital organ assessment in critically ill patients, it is important to identify its determinants.

The aim of this prospective observational cohort study was to determine whether RRI is higher in patients with shock than in patients without shock. The secondary aim was to identify determinants of RRI.

MATERIALS AND METHODS
=====================

The study was performed at Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Intensive Care Medicine, Amsterdam, the Netherlands, and is part of a larger project that additionally determines the predictive value of RRI for the development of AKI ([@R9]). The study was approved by the Ethical Board of the VUmc, which allowed a deferred consent procedure to obtain signed consent for the use of the data (VU University Medical Centre Protocol Record METC-2015.025).

Setting and patients
--------------------

Adult critically ill patients admitted to the intensive care unit (ICU) were included consecutively. Patients were subsequently allocated to the shock and nonshock group. Inclusion criteria in the shock group were shock due to sepsis, systemic inflammatory response syndrome (SIRS), and cardiac failure or hemorrhage. Inclusion criteria in the nonshock group were non- or short-term circulatory dependency of fluids and vasopressors. Exclusion criteria were severe renal insufficiency (eGFR \<30 mL/min), dialysis dependency, renal transplantation, monokidney, treatment restrictions, admission after suicide attempt, and inability to obtain informed consent due to cognitive impairment. Weekend admissions were not included because investigators were not present.

Definitions
-----------

*Shock* was defined as vasopressor-dependent hypotension or low cardiac index (\<2 L/min/m^2^ as measured with thermodilution or qualitatively as assessed by Doppler ultrasound) unresponsive to adequate fluid resuscitation, in the presence of perfusion abnormalities, manifest by oliguria, reduced peripheral perfusion, hyperlactatemia (lactate \>2 mmol/L), or organ dysfunction ([@R10]). Patients with hypotension or low cardiac index, who were easily responsive to short-term vasopressor support or fluids, and without peripheral perfusion abnormalities, were not considered as being in shock. A low vasopressor dose during propofol sedation was therefore not diagnosed as shock. SIRS, sepsis, and septic shock were defined according to standard criteria ([@R11]). We additionally compared the RRI between subgroups using different criteria of compromised circulation: a cutoff value of serum lactate (3 mmol/L) with and without the need of vasopressors.

Study protocol
--------------

Within 24-h of ICU admission, three study measurements were performed within the time frame of 1-h: renal resistive index (RRI), the sublingual microcirculation using sidestream dark field (SDF) imaging, and bioelectral impedance analysis (BIA). All measurements were performed in accordance with relevant guidelines and regulations. The other biochemical and clinical parameters were obtained simultaneously; especially hemodynamic parameters were taken at the same time as the RRI measurements. The investigators were not blinded for inclusion criteria. All patients using vasopressors were allocated to the shock or nonshock group by the same senior investigator, intensivist, who was blinded for the RRI results, based on the aforementioned criteria.

Renal resistive index
---------------------

RRI was determined using Doppler ultrasound. A transparietal 5 MHz pulsed-wave Doppler probe (C5-1 ultrasound transducer, Philips Medical Systems International B.V., Best, The Netherlands) on a CX50 ultrasound system was used. A previous study showed a good interobserver reliability between junior and senior operators: interclass correlation coefficient (ICC), 89% (95% confidence interval \[CI\], 82%--93%) ([@R12]). Each final RRI was based on 18 measurements. After visualizing the kidney, an interlobar or arcuate artery from the upper, middle, and lower part of each kidney was selected to obtain three pulse wave Doppler measurements for each artery. The median of these three RRI determinations was selected for each artery. For each kidney, we calculated mean RRI based on the three median RRI determinations. RRI is defined as ((peak systolic velocity−end diastolic velocity)/peak systolic velocity). Normal values are reported between 0.60 and 0.70 ([@R13]).

Sublingual microcirculation
---------------------------

Sublingual microcirculation was manually assessed with SDF imaging, a light-absorption-based technique using a hand-held video microscope (the Microscan. Firma) ([@R14]). Afterward, an independent investigator analyzed the videos by visual inspection using a cutoff point of 20 μm for small vessels. Flow was graded by vessel density (VD; n/mm), perfused vessel density (PVD; n/mm), proportion of perfused vessels (PPV; %), and microvascular flow index (MFI), quantifying the predominant type of flow in four quadrants: no flow \[0\], intermittent flow \[1\], slow/sluggish flow \[2\], and continuous flow \[3\]. Heterogeneity indexes (HI) were calculated for PVD, PPV, and MFI. The mean of three to five different sublingual sites was calculated.

Bioelectral impedance analysis (BIA)
------------------------------------

Whole body BIA was measured using the phase sensitive Akern BIA 101 Anniversary edition (GLNP Life Sciences) device with an alternating current of 400 μA and a frequency of 50 kHz. BIA measures resistance (R), mainly reflecting extracellular resistance (hydration status), reactance (Xc), reflecting membrane capacitance (cellular mass and integrity), and calculates the phase angle, the arc tangens of ((Xc/R) × (180/π)). Resistance and reactance are expressed per meter. Resistance and phase angle decrease along with an increase in total body water. Reactance mainly decreases with membrane injury or decreases in cell mass ([@R15]).

Other parameters
----------------

The following standard clinical variables were collected: mean arterial pressure (MAP), heart rate (HR), cardiac index (CI), central venous pressure (CVP), arterial lactate, norepinephrine dose and central or mixed venous oxygen saturation (SvO~2~), demographic data, and the acute physiology and chronic health evaluation III (APACHE III) score. Pulse pressure index (PPI) was calculated as ((systolic−diastolic)/systolic pressure) obtained from continuous invasive arterial pressure monitoring. Cardiac ultrasound was performed routinely in the unit in patients with hypotension not responding to fluids. Concomitant renal function and damage were measured by creatinine clearance (4-h portion), fractional excretion of sodium (FENa) = (urinary sodium × plasma creatinine)/(plasma sodium × urinary creatinine), fractional excretion of urea (FEUrea) = (urinary urea × plasma creatinine)/(plasma urea × urinary creatinine), and albumin/creatinine ratio. In addition, preadmission glomerular filtration rate (eGFR) was estimated based on a stable serum creatinine before ICU admission. All clinical and biochemical measurements were retrieved from the patient data management system (Metavision, IMD Soft, Tel Aviv, Israel).

Sample size
-----------

Power calculations were based on an estimated mean RRI of 0.78 in the shock patients and an RRI of 0.70 in the nonshock patients with a standard deviation (SD) of 0.12 ([@R5]). To be able to detect this difference with a power of 0.80 (1−β) and a significance level of 0.05 (α), 36 patients were needed in each group. To compensate for missing data, we aimed to include at least 40 patients in each arm.

Statistical analysis
--------------------

Normally distributed variables are reported as mean ± SD and not-normally distributed variables as median \[interquartile range\]. Normality was tested using skewness and the one-sample Kolmogorov--Smirnov test. For comparison of continuous variables between patients with and without shock, an independent two-tailed *t* test was used or the Mann--Whitney *U* test as appropriate. A *P* value of \<0.05 was considered to be statistically significant.

To evaluate the relation between RRI (as continuous variable) and markers of the macro- and microcirculation, hydration status, membrane capacitance, and renal function, potential determinants were initially tested by univariable regression analysis. Subsequently, backward stepwise selection was computed with all variables of interest that were significantly related to RRI on univariable regression analysis. The alpha-to-remove was 0.10. Missing variables were imputed in 20 new datasets, using predictive mean matching (PMM) and a maximum of 50 iterations. Finally, the remaining independent determinants of RRI, that were presented in the pooled model, were entered in multivariable regression analysis to generate a predictive model for RRI, including a maximum of n/10 predictors ([@R16]). The reported mean adj. *R*^2^ was calculated from the 20 generated models. A sensitivity analysis was performed with the unimputed data.

RESULTS
=======

From August 2015 until February 2016, a total of 518 patients were admitted to the ICU (Fig. [1](#F1){ref-type="fig"}). A total of 351 patients were not included due to weekend admission, nonavailability of the ultrasound device, inability to acquire adequate imaging, or completion of inclusion (in the nonshock group). Mean age and APACHE III scores of the nonincluded shock patients were not significantly different from the included shock patients (data not shown). Mean time to inclusion after ICU admission was 9.6-h. Time between RRI, SDF, and BIA measurements was less than 1-h.

![Flowchart of included patients. Inability to acquire adequate imaging was due to morbid obesity, wounds, immobility (after trauma), or agitation.](shk-52-43-g001){#F1}

Of the 95 enrolled patients, 3 were excluded afterward because deferred consent for the use of data was not obtained. Finally, 92 patients were analyzed: 40 with shock and 52 without shock. Among the patients with shock, 29 (72.5%) had cardiogenic shock, 3 (7.5%) had hypovolemic shock, 6 (15.0%) had septic shock, and 2 (5.0%) had shock due to SIRS.

Baseline characteristics
------------------------

Baseline characteristics are shown in Table [1](#T1){ref-type="table"}. Patients with shock had a significantly higher APACHE III score, arterial lactate, plasma creatinine, and FEUrea, as well as a more positive fluid balance. Moreover, norepinephrine was more often administered and norepineprine dose was higher (Table [1](#T1){ref-type="table"}). In the nonshock group, 5 patients, without signs of oliguria or disturbed peripheral perfusion, temporarily received low-dose norepinephrine during propofol sedation.

###### 

Baseline characteristics of the study population (n = 92)

                                                                              Patients with shock (n = 40)   Patients without shock (n = 52)   *P*
  --------------------------------------------------------------------------- ------------------------------ --------------------------------- ---------
  Age, y                                                                      69 \[60--76\]                  67 \[59--76\]                     0.541
  Sex                                                                                                                                          0.859
   Male, %                                                                    67.5                           69.2                              
   Female, %                                                                  32.5                           30.8                              
  BMI, kg/m^2^                                                                25.2 ± 4.3                     26.2 ± 4.3                        0.280
  APACHE III                                                                  87 \[65--119\]                 57 \[45--69\]                     \<0.001
  Lactate                                                                     2.5 \[1.4--4.3\]               1.2 \[0.9--2.0\]                  \<0.001
  Risk factors of AKI                                                                                                                          
   Chronic kidney disease[^\*^](#TF1-1){ref-type="table-fn"}, n (%)           8 (20.0)                       8 (15.4)                          0.563
   Sepsis, n (%)                                                              6 (15.0)                       5 (9.6)                           0.430
   History of hypertension, n (%)                                             12 (30.0)                      21 (40.4)                         0.303
   Diabetes, n (%)                                                            8 (20.0)                       9 (17.3)                          0.742
  Subgroups of admission                                                                                                                       
   Elective surgical, n (%)                                                   18 (45.0)                      32 (61.5)                         0.114
   Emergency surgical, n (%)                                                  5 (12.5)                       3 (5.8)                           0.256
   Medical, n (%)                                                             17 (42.5)                      17 (32.7)                         0.334
  Renal function                                                                                                                               
   Serum creatinine, μmol/L                                                   91 \[76--122\]                 75 \[62--84\]                     \<0.001
   Pre-admission eGFR, mL/min                                                 71 ± 15                        76 ± 14                           0.102
  Urinary indices                                                                                                                              
   FENa[^†^](#TF1-2){ref-type="table-fn"}, %                                  0.4 \[0.2--1.0\]               0.6 \[0.3--1.5\]                  0.314
   FEUrea[^‡^](#TF1-3){ref-type="table-fn"}, %                                31.9 \[20.9--37.6\]            37.2 \[27.6--44.9\]               0.024
   Albumin/creatinine ratio[^§^](#TF1-4){ref-type="table-fn"}                 4.2 \[1.2--11.4\]              2.8 \[1.6--5.4\]                  0.102
   Creatinine clearance[^\|\|^](#TF1-5){ref-type="table-fn"}, mL/min          52.3 \[29.2--100.3\]           110.8 \[79.5--149.6\]             \<0.001
  Hemodynamics                                                                                                                                 
   Heart rate (HR; bpm)                                                       87 \[71--93\]                  78 \[70--88\]                     0.209
   Mean arterial pressure (MAP; mmHg)                                         70 \[64--78\]                  73 \[66--86\]                     0.171
   Pulse pressure index (PPI)                                                 0.456 ± 0.087                  0.483 ± 0.074                     0.121
   Central venous pressure[^¶^](#TF1-6){ref-type="table-fn"} (CVP; cmH~2~O)   10 \[6--14\]                   7 \[4--10\]                       0.007
   Cardiac index[^\*\*^](#TF1-7){ref-type="table-fn"} (CI)                    2.1 \[1.8--2.3\]               2.1 \[1.9--2.8\]                  0.423
   SvO~2~[^††^](#TF1-8){ref-type="table-fn"}, %                               66 \[61--75\]                  68 \[65--72\]                     0.403
   Norepinephrine[^‡‡^](#TF1-9){ref-type="table-fn"}, n (%)                   37 (92.5)                      5 (9.6)                           \<0.001
   Norepinephrine dose, μg/kg/min                                             0.27 \[0.14--0.44\]            0 \[0.0--0.0\]                    \<0.001
   Fluid balance[^§§^](#TF1-10){ref-type="table-fn"}, mL                      3075 \[1466--5025\]            528 \[−79 to 938\]                \<0.001

BMI, body mass index; APACHE, acute physiology and chronic health evaluation; AKI, acute kidney injury; eGFR, estimated glomerular filtration rate; FENa, fractional excretion of sodium; FEUrea, fractional excretion of urea; SvO~2~, central or mixed venous oxygen saturation.

Data are presented as mean ± SD or as median with \[interquartile range\].

^\*^Chronic kidney disease was defined as an eGFR before ICU admission of 30 to 60 mL/min; patients with eGFR \<30 mL/min on admission were not included.

^†^n = 40 vs. n = 49.

^‡^n = 40 vs. n = 48.

^§^n = 39 vs. n = 50.

^\|\|^Creatinine clearance (4-h portion), n = 40 vs. n = 51.

^¶^n = 33 vs. n = 35.

^\*\*^n = 16 vs. n = 14.

^††^n = 31 vs. n = 35.

^‡‡^Norepinephrine support during the measurements.

^§§^Fluid balance from ICU admission until measurements (\<24-h after admission).

Primary endpoint: shock versus nonshock
---------------------------------------

### Renal resistive index

RRI could be measured only one-sided in two patients (one with shock, one without). In 7 additional patients, one or two of the six regional RRI measurements were missing because no more vessels could be visualized. The RRI did not significantly differ between the left and right kidney. Patients with shock had a significantly higher RRI than patients without shock (0.751 \[0.692--0.788\] vs. 0.654 \[0.610--0.686\], respectively, *P* \< 0.001) (Fig. [2](#F2){ref-type="fig"} and Table [2](#T2){ref-type="table"}). RRI was not significantly different between patients with septic shock (n = 6) and other shock (n = 34): 0.760 \[0.647--0.789\] vs. 0.751 \[0.694--0.789\] respectively, *P* = 0.956.

![Renal resistive index of patients admitted with shock (n = 40) and without shock (n = 52).](shk-52-43-g002){#F2}

###### 

Study parameters

                                                                           Patients with shock      Patients without shock   *P*
  ------------------------------------------------------------------------ ------------------------ ------------------------ ---------
  Renal resistive index (RRI)[^\*^](#TF2-1){ref-type="table-fn"}                                                             
   Left kidney                                                             0.757 \[0.690--0.792\]   0.656 \[0.596--0.696\]   \<0.001
   Right kidney                                                            0.746 \[0.693--0.786\]   0.656 \[0.621--0.690\]   \<0.001
   Overall                                                                 0.751 \[0.692--0.788\]   0.654 \[0.610--0.686\]   \<0.001
  Microcirculation (SDF)[^†^](#TF2-2){ref-type="table-fn"}                                                                   
   Vessel density (VD; n/mm)                                               9.5 ± 1.6                9.7 ± 2.6                0.698
   Perfused vessel density (PVD; n/mm)                                     7.0 ± 1.4                7.1 ± 2.1                0.747
   Percentage of perfused vessels (PPV; %)                                 73.9 ± 12.1              73.1 ± 14.0              0.817
   Microvascular flow index (MFI)[^‡^](#TF2-3){ref-type="table-fn"}        2.0 ± 0.5                2.0 ± 0.5                0.926
  Bioelectral impedance analysis (BIA)[^§^](#TF2-4){ref-type="table-fn"}                                                     
   Resistance (R/m)                                                        285.0 \[245.9--324.9\]   285.1 \[255.1--326.6\]   0.585
   Reactance (Xc/m)                                                        22.1 \[17.4--29.2\]      24.3 \[21.6--29.8\]      0.075
   Phase angle                                                             4.3 \[3.3--5.4\]         4.9 \[4.0--6.1\]         0.066

SDF, sidestream dark field.

Data are presented as mean ± SD or as median with \[interquartile range\].

^\*^n = 40 vs. n = 52.

^†^n = 32 vs. n = 36.

^‡^No flow \[0\], intermittent flow \[1\], slow/sluggish flow \[2\], and continuous flow \[3\].

^§^n = 39 vs. n = 50.

A comparison of RRI between subgroups using other criteria of compromised circulation is shown in Table [3](#T3){ref-type="table"}.

###### 

Renal resistive index in different subgroups

                                                          No. of patients     Renal resistive index                               *P*
  ------------------------------------------------------- ------------------- --------------------------------------------------- ---------
  Shock vs. nonshock[^\*^](#TF3-1){ref-type="table-fn"}   n = 40 vs. n = 52   0.751 \[0.692--0.788\] vs. 0.654 \[0.610--0.686\]   \<0.001
  Lactate ≥3 vs. \<3 mmol/L                               n = 22 vs. n = 70   0.720 \[0.673--0.779\] vs. 0.672 \[0.626--0.735\]   0.034
  Lactate ≥3 mmol/L + VP support vs. other                n = 16 vs. n = 76   0.751 \[0.687--0.781\] vs. 0.674 \[0.626--0.734\]   0.016

VP, vasopressor.

Data are presented as median with \[interquartile range\].

^\*^According to the clinical criteria as described above.

### Sublingual microcirculation

The sublingual microcirculation was visualized in 68/92 (73.9%) patients. In 24 patients (26.1%), the SDF measurement could not be performed due to the inability to open the mouth, instable cervical fractures, abundant secretions, or agitation. None of the microcirculatory markers differed between shock and nonshock patients (Table [2](#T2){ref-type="table"}).

### Bioimpedance analysis

BIA measurements were performed in 89/92 (96.7%) patients. BIA could not be performed due to the inability to position the electrodes in three patients (3.3%). Resistance/m was not significantly different between shock and nonshock patients (Table [2](#T2){ref-type="table"}). However, reactance/m and phase angle tended to be lower in the shock patients.

Secondary endpoints: determinants of RRI
----------------------------------------

### Univariable regression analysis

*Systemic circulation.* Due to the absence of a central catheter or a cardiac output device in the less severely ill patients, the number of patients with an available CI, CVP, and SvO~2~ was limited (Table [4](#T4){ref-type="table"}). RRI was inversely related to MAP (*R* = −0.30) and positively to vasopressor support (*R* = 0.51), CVP (*R* = 0.50), norepinephrine dose (*R* = 0.39), and PPI (*R* = 0.36). RRI was not related to HR, CI, and SvO~2~ (Table [4](#T4){ref-type="table"}).

###### 

Univariable regression analysis

  Variable                                                                  n    Regression coefficient *B*[^\*^](#TF4-1){ref-type="table-fn"}   95% CI *B*       SE of *B*   Correlation coefficient *β*   *P*
  ------------------------------------------------------------------------- ---- --------------------------------------------------------------- ---------------- ----------- ----------------------------- ---------
  Systemic circulation                                                                                                                                                                                      
   Heart rate (HR; bpm)                                                     92   0.000                                                           −0.001--0.001    0.001       −0.07                         0.535
   Mean arterial pressure (MAP; mmHg)                                       92   −0.002                                                          −0.004--−0.001   0.001       −0.30                         0.004
   Pulse pressure index (PPI)                                               92   0.367                                                           0.167--0.567     0.101       0.36                          \<0.001
   Central venous pressure (CVP; cmH~2~O)                                   68   0.009                                                           0.005--0.013     0.002       0.50                          \<0.001
   Cardiac index (CI)                                                       30   −0.033                                                          −0.111--0.045    0.038       −0.16                         0.395
   Venous oxygen saturation (SvO~2~; %)[^†^](#TF4-2){ref-type="table-fn"}   66   0.001                                                           −0.001--0.004    0.001       0.12                          0.354
   Vasopressor support[^‡^](#TF4-3){ref-type="table-fn"}                    92   0.083                                                           0.054--0.113     0.015       0.51                          \<0.001
   Norepinephrine dose, μg/kg/min                                           92   0.144                                                           0.072--0.216     0.036       0.39                          \<0.001
  Microcirculation                                                                                                                                                                                          
   Vessel density (VD; n/mm)                                                68   −0.004                                                          −0.014--0.005    0.005       −0.11                         0.370
   Perfused vessel density (PVD; n/mm)                                      68   −0.008                                                          −0.019--0.003    0.005       −0.12                         0.149
   Percentage of perfused vessels (PPV; %)                                  68   −0.001                                                          −0.002--0.001    0.001       −0.13                         0.300
   Microvascular flow index (MFI)                                           68   −0.032                                                          −0.070--0.005    0.019       −0.21                         0.092
  Hydration                                                                                                                                                                                                 
   Fluid balance, L[^§^](#TF4-4){ref-type="table-fn"}                       92   0.011                                                           0.005--0.017     0.003       0.34                          0.001
   Resistance (R/m)                                                         89   0.000                                                           0.000--0.000     0.000       −0.12                         0.281
   Reactance (Xc/m)                                                         89   −0.003                                                          −0.005--−0.001   0.001       −0.34                         0.001
   Phase angle                                                              89   −0.011                                                          −0.021--−0.001   0.005       −0.23                         0.031
  Concomitant renal function                                                                                                                                                                                
   Creatinine clearance, mL/min[^\|\|^](#TF4-5){ref-type="table-fn"}        91   −0.001                                                          −0.001--0.000    0.000       −0.42                         \<0.001
   FEUrea, %                                                                88   −0.002                                                          −0.003--0.000    0.001       −0.24                         0.022
   FENa, %                                                                  89   −0.015                                                          −0.030--0.001    0.008       −0.20                         0.067
   Albumin/creatinine ratio                                                 89   0.000                                                           −0.001--0.000    0.000       −0.05                         0.637
  Other                                                                                                                                                                                                     
   Age, y                                                                   92   0.002                                                           0.001--0.003     0.001       0.30                          0.004
   APACHE III                                                               92   0.001                                                           0.000--0.001     0.000       0.37                          \<0.001
   Lactate, mmol/L                                                          92   0.015                                                           0.004--0.025     0.005       0.28                          0.006
   Preadmission eGFR, mL/min                                                92   −0.002                                                          −0.003--−0.001   0.001       −0.30                         0.004
   BMI, kg/m^2^                                                             92   0.000                                                           −0.004--0.004    0.002       −0.02                         0.834

SE, standard error; FEUrea, fractional excretion of urea; FENa, fractional excretion of sodium; APACHE, acute physiology and chronic health evaluation; eGFR, estimated glomerular filtration rate; BMI, body mass index.

^\*^If *X* increases with 1, RRI increases with *B*. Variable = *X*.

^†^Central or mixed venous oxygen saturation.

^‡^0 = no vasopressor support; 1 = vasopressor support.

^§^Fluid balance from ICU admission until measurements (\<24-h after admission).

^\|\|^Creatinine clearance (4-h portion).

#### Microcirculation

None of the microcirculatory markers were significantly related to the RRI (Table [4](#T4){ref-type="table"}).

#### Hydration and membrane capacitance

RRI was inversely related to reactance/m (*R* = −0.34) and phase angle (*R* = −0.23) and positively to fluid balance (*R* = 0.34). RRI was not related to resistance/m (Table [4](#T4){ref-type="table"}).

#### Other related variables

RRI was inversely related to actual creatinine clearance (*R* = −0.42), preadmission eGFR (*R* = −0.30), and FEUrea (*R* = −0.24), but not to FENa and albumin/creatinine ratio. RRI was positively related to APACHE III score (*R* = 0.37), age (*R* = 0.30), and arterial lactate (*R* = 0.28) (Table [4](#T4){ref-type="table"}).

### Multivariable regression analysis

Vasopressor support, MAP, PPI, CVP, fluid balance, reactance/m, age, APACHE III score, arterial lactate, and preadmission eGFR were included for backward stepwise selection. Missing variables were imputed for CVP (24/92 (26.1%)) and reactance/m (3/92 (3.3%)). In the pooled model vasopressor support, CVP, PPI, MAP, reactance/m, and preadmission eGFR remained as independent determinants of RRI. These variables constituted the final predictive model (Table [5](#T5){ref-type="table"}). Participants constant RRI was 0.601. RRI increased when vasopressors were used, along with a higher CVP, higher PPI, lower MAP, lower reactance/m, and lower preadmission eGFR. The final model explained 58.7% of the variance of RRI. When performing a sensitivity analysis on the unimputed data, vasopressor support, CVP, PPI, and MAP remained as independent predictive determinants of RRI (n = 68, adj. *R*^2^ = 0.608, standard error of estimate = 0.049). Furthermore, when forcing MFI into the model, this microcirculatory marker was removed.

###### 

Multivariable regression analysis

                                                            Final model                           
  --------------------------------------------------------- ------------- --------------- ------- ---------
  *Constant*                                                0.601         0.476--0.726    0.064   \<0.001
  Systemic circulation                                                                            
   Vasopressor support[^\*^](#TF5-1){ref-type="table-fn"}   0.059         0.035--0.084    0.012   \<0.001
   Central venous pressure (CVP; cmH~2~O)                   0.006         0.003--0.009    0.002   \<0.001
   Pulse pressure index (PPI)                               0.418         0.275--0.561    0.073   \<0.001
   Mean arterial pressure (MAP; mmHg)                       −0.001        −0.002--0.000   0.001   0.006
  Membrane capacitance                                                                            
   Reactance (Xc/m)                                         −0.001        −0.003--0.000   0.001   0.045
  Renal function                                                                                  
   Pre-admission eGFR, mL/min                               −0.001        −0.002--0.000   0.000   0.097

RRI = 0.601 + vasopressor support × 0.059 + CVP × 0.006 + PPI × 0.418 -- MAP × 0.001 -- reactance/m × 0.001 -- preadmission eGFR × 0.001.

^\*^0 = no vasopressor support; 1 = vasopressor support.

Sample size = 92; mean adjusted *R*^2^ = 0.587 \[minimum 0.552 − maximum 0.638\]; mean standard error of estimate = 0.053.

SE indicates standard error.

DISCUSSION
==========

This prospective observational cohort study shows that Doppler ultrasound-derived renal resistive index (RRI) was higher in patients admitted to the ICU with shock than in patients without shock. It also shows that RRI was determined by *pressure* markers of the systemic circulation, membrane capacitance, and preadmission renal function and not by markers of *flow* in the systemic- and the microcirculation.

Our study is the first comparing the RRI of shock and nonshock patients in the ICU. Apart from a clinical definition, we additionally used other criteria of compromised circulation, including a lactate cutoff with or without the need of vasopressor support. Our results seem robust because RRI was increased in patients with shock using different criteria. A previous study from the emergency department reported that patients with hemorrhagic shock had a higher RRI than those without (mean, 0.80 ± 0.10 vs. 0.63 ± 0.03) ([@R17]). In our cohort, RRI values in the nonshock patients were comparable, but RRI in our shock patients was lower, median 0.751 \[0.692--0.788\], possibly due to already initiated resuscitation. On average, our patients were included 9.6-h (mean) after ICU admission.

The present study also found that high RRI was related to low MAP and vasopressor support. Previous studies in septic patients without AKI ([@R18]), septic shock ([@R19], [@R20]), acute circulatory failure ([@R21]), and healthy controls ([@R22], [@R23]) also found an inverse relation between RRI and MAP. However, in septic AKI ([@R18]) and postoperative cardiac surgery ([@R24]), MAP was not related to RRI. In six studies in mixed ([@R5], [@R21], [@R25]) and septic populations ([@R18], [@R19], [@R26]), RRI and vasopressor support were not related, whereas others found that RRI decreased when MAP was increased with norepinephrine ([@R20]). In general, RRI can increase due to intrarenal vasoconstriction if flow remains constant or due to increased flow with similar vessel diameter ([@R3]). Hypotension triggers vasoconstriction as an adaptive response and thereby increases RRI. Hypotension also triggers the clinician to give norepinephrine. Norepinephrine can lower RRI by reducing venous capacitance and increasing cardiac preload, blood pressure, and kidney perfusion ([@R20]). On the contrary, norepinephrine may increase RRI by direct vasoconstriction. This relation was found in our patients, maybe indicating that "too much" vasopressors were used or that renal vasoconstriction is not directly reversible after restoration of hypotension, as demonstrated in experimental sepsis ([@R27]) and in septic patients with AKI ([@R18]). The combined relation between MAP, norepinephrine, and RRI in our study suggests that both hypotension and vasopressor support could contribute to renal vasoconstriction.

RRI was strongly related to the PPI, the *ratio* of the pulse pressure to the systolic pressure. PPI reflects vascular compliance ([@R28]). In our patients, high PPI, e.g., arterial stiffness, could be due to underlying arterial disease or to vasoconstriction. A strong relation between RRI and pulse pressure was reported in isolated perfused rabbit kidneys ([@R29]) and in patients ([@R13], [@R23], [@R30]--[@R32]). *In vitro*, RRI was more affected by resistance when compliance was higher ([@R33]). The inverse relation between RRI and preadmission eGFR in our patients may be related to underlying arterial disease or capillary rarefaction due to preadmission renal disease. Finally, CVP appeared as a strong independent determinant of RRI. A relation between RRI and CVP has not been reported before, but has a strong pathophysiological rationale because high CVP increases resistance to flow.

Our results further suggest that RRI was not related to measured flow indices: cardiac index and the sublingual microcirculation. Unfortunately, cardiac index, which is not part of standard monitoring anymore, was only available in one-third of the patients, mainly cardiac surgery patients. Although the interrelation between flow, pressure, and RRI is complex, our study suggests that RRI is less related to markers of flow. However, we did not measure the renal microcirculation. Nowadays, the renal microcirculation can be assessed with contrast-enhanced ultrasound. A recent pilot study in patients requiring norepinephrine found great variability in pressure responsiveness of the renal microcirculation ([@R34]).

RRI was related to fluid balance on univariable but not on multivariable analysis. In some previous studies, hemodynamic changes induced by fluid challenges did not result in changes in RRI ([@R26], [@R35]). However, another study found that fluids decreased RRI and increased urine output ([@R21]). Interestingly, BIA-derived reactance/m (membrane capacitance) appeared as an independent determinant of RRI in our study. Reactance/m also tended to be lower in patients with shock. In our patients, low reactance may represent poor underlying condition, but also the consequence of shock, e.g., capillary leakage. This suggests that membrane injury may contribute to an increased RRI.

*Strenghts.* Although several studies reported relations between RRI and hemodynamic variables, this is the first study comparing RRI between patients with and without shock and analyzing the combined determinants of RRI in a mixed ICU population. Our model, including pressure markers of the systemic circulation, a marker of cell and membrane quality (reactance/m), and preadmission eGFR (a marker of preexisting vascular disease), explained about 60% of the variability of RRI. However, given the sample size of the study, there might be some overfitting. Unknown determinants were also suggested in literature ([@R8]). To minimize intraobserver variability, each final RRI was based on 18 measurements. A good interobserver reliability was already shown in a previous study ([@R12]). A third blinded investigator performed the SDF analysis, minimizing information bias. Selection bias was minimized because allocation to the shock group was performed by the senior investigator who was blinded for the RRI results. Finally, all measurements were performed in a short time frame, thereby optimizing the reliability of the relations with RRI.

*Limitations.* First, CI was only measured in one-third of the patients. Importantly, CI was not related to RRI on univariable analysis. There was not even a trend. Second, in the multivariable analysis we imputed for missing CVP values. However, results were similar on sensitivity analysis using unimputed data only. Third, the sample size was too small to assess the different types of shock separately. However, RRI was not different between patients with septic shock and other shock, and the final model was not influenced by excluding septic shock patients from the analysis (data not shown). Unfortunately, the proportion of septic shock patients was very low (in line with the proportion admitted to our ICU). Increased awareness of sepsis and early administration of antibiotics could be an explanation. Notably, CI and sublingual microcirculatory markers were not different between patients with or without shock. An explanation could be that during surgery a restricted fluid strategy is presently applied and that cardiac surgery patients often have low cardiac index postoperatively due to hypovolemia during rewarming while not fulfilling the shock criteria. Fourth, eligible patients were not included over the weekend. However, age and severity of illness of the nonincluded eligible shock patients were similar. Fifth, we visualized the microcirculation under the tongue, which might differ from the kidney. Furthermore, SDF could not be performed in 26.1% of the patients. Sixth, the interval between ICU admission and the measurement of RRI differed between patients. This might be a drawback; however, shock treatment and the illness duration before admission also differ between patients. Thus, lead-time bias may confound the observations but is partially inevitable. Altogether, our findings contribute to the knowledge about the renal vascular response to changes in the systemic circulation. However, a causative relation cannot be shown, nor whether the vasoconstrictive response is harmful or adaptive.

The present study explained about 60% of the variability of RRI. Previous studies found that high RRI was a predictor of AKI. Because vasopressor support showed the strongest independent relation with a high RRI and because high RRI predicts the development of AKI during the first week of ICU admission ([@R9]), our findings could indicate that too much vasopressors might unnecessarily increase renal vasoconstriction and subsequently contribute to the development of AKI. Measuring RRI using bedside ultrasound could be part of the assessment of vital organ status and function. Further studies are needed to validate our results, to find the remaining determinants of RRI, including the renal microcirculation, and to show whether RRI can be used to guide vasopressor dosing during shock resuscitation and thereby mitigate the development of AKI.

CONCLUSIONS
===========

The present observational study shows that patients with shock have a higher RRI than critically ill patients without shock. Furthermore, independent determinants of high RRI were pressure indices of the systemic circulation, low membrane capacitance, and preadmission renal dysfunction, a surrogate marker for underlying vascular disease. Flow markers such as cardiac index and the sublingual microcirculation were not. Further studies are needed to show whether RRI can be used to guide vasopressor dosing during shock resuscitation to mitigate AKI.
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